These results suggest that through alleviating ferroptosis inhibition and gemcitabine resistance induced by METTL3 overexpression, HMGB1 contributes to cellular responses in pancreatic cancer cells. The gene discussed is METTL3; the disease is familial pancreatic carcinoma.